You are here: All Products  > Livzon Acquires Rights to GERD Therapy from Onconic for $127.5 Million

Livzon Acquires Rights to GERD Therapy from Onconic for $127.5 Million

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products